Skip to main content

Theuer Charles

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Theuer Charles as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

TCON Tracon Pharmaceuticals, Inc.

PRESIDENT AND CEO22 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 28, 2023 (view filing)Apr 26-272 daysTheuer CharlesPresident and CEOPPurchase+51.0K$0.7429+$37.9K+14.6%399.4K after2 lots
Mar 2, 2023 (view filing)Feb 28-Mar 12 daysTheuer CharlesPresident and CEOPPurchase+5.00K$1.52+$7.60K+1.5%344.9K after2 lots
Jan 19, 2023 (view filing)Jan 181 dayTheuer CharlesPresident and CEOPPurchase+6.80K$1.62+$11.0K+2.0%339.9K after
Dec 15, 2022 (view filing)Dec 141 dayTheuer CharlesPresident and CEOPPurchase+23.0K$1.29+$29.7K+7.4%333.1K after
Nov 22, 2022 (view filing)Nov 184 daysTheuer CharlesPresident and CEOPPurchase+13.9K$1.41+$19.6K+4.7%310.1K after
Nov 4, 2022 (view filing)Nov 31 dayTheuer CharlesPresident and CEOPPurchase+9.20K$1.52+$14.0K+3.2%296.2K after
Nov 3, 2022 (view filing)Nov 21 dayTheuer CharlesPresident and CEOPPurchase+6.00K$1.59+$9.54K+2.1%287.0K after
Oct 11, 2022 (view filing)Oct 74 daysTheuer CharlesPresident and CEOPPurchase+5.00K$1.77+$8.85K+1.8%277.5K after
Oct 5, 2022 (view filing)Oct 32 daysTheuer CharlesPresident and CEOPPurchase+5.00K$1.67+$8.35K+1.9%272.5K after
Sep 26, 2022 (view filing)Sep 224 daysTheuer CharlesPresident and CEOPPurchase+5.00K$1.76+$8.80K+1.9%267.5K after

See all 22 trades at TCON